Systematic review of influence of CYP2C19 genetic polymorphism on pharmacokinetics of omeprazole / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 374-379, 2013.
Artigo
em Chinês
| WPRIM
| ID: wpr-860462
ABSTRACT
OBJECTIVE:
To evaluate the influence of CYP2C19 genetic polymorphism on omeprazole pharmacokinetics.METHODS:
Cochrane library, PubMed, Embase and CNKI databases were searched for trials investigating the influence of CYP2C19 genetic polymorphism on omeprazole pharmacokinetics reported before February 2012.Meta-analysis was performed by RevMan 5.1 software.RESULTS:
Twelve retrospective studies, eight in English and four in Chinese, were included. Meta-analysis showed that CYP2C19 polymorphism significantly influenced the ρmax, AUC, t1/2 and CL/F. The ρmax, AUC, t1/2 and CL/F in PM genotype group were higher than those in HEM group, and those in HEM group were significantly higher than in EM group. And the CL/F in EM group was significantly higher than that in HEM group followed by that in PM group.CONCLUSION:
CYP2C19 genetic polymorphism affects omeprazole exposure significantly, but there are still other influencing factors. Large prospective studies are needed.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Estudo observacional
/
Revisões Sistemáticas Avaliadas
Idioma:
Chinês
Revista:
Chinese Pharmaceutical Journal
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS